PSM India www.safemedicinesindia.in Bejon Misra, Founder Director.

Slides:

Advertisements

Similar presentations

REGULATING AFLATOXIN CONTAMINATION IN FOOD PRODUCTS BY RAYMOND N. WIGENGE Director of Food Safety Tanzania Food and Drugs Authority.

Advertisements

الرابطة الدولية لمكافحة المواد الطبيّة المزورة a WHO initiative to combat counterfeit medical products Dr V. Reggi - World Health Organization.

1 4 th Global Congress, Dubai 3 rd – 5 th February 2008.

NCPIE CMI Initiative. Education Committee Members American Pharmacists Association First DataBank National Assn. of Boards of Pharmacy National Assn.

Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.

India Injection Safety Coalition. If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple.

Session 6 : Need for good governance Importance of veterinary legislation and its appropriate implementation Jean-Luc ANGOT, CVO, France 14 March 2013.

Promoting patient-centred healthcare around the world Advancing the fight against counterfeit medicines Ms. Regina Kamoga IAPO Board Member, Country Manager,

World Health Organization

Patents pending Uniquely Identifying Your Products and Consumers Nakul Pasricha, COO 23 rd July, 2014 PharmaSecure, New York 601 West 26th Street, Suite.

Industry's Role in Promoting Best Practices A Collaborative Approach to Food Safety Global Food Safety Policy Forum Washington DC September 16, 2011.

Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.

U.S. Drug Supply Chain Integrity: Protecting Patient Safety CDR Connie Jung, PharmD, PhD LCDR Eleni Anagnostiadis, RPh Office of Drug Security, Integrity,

A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford,

Counterfeit Medicines and Fight against Counterfeit Medicines.

Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone | Director, Consumer Global Brand Protection.

Quality of Emergency Contraceptive Pills: Should we worry? Elizabeth Westley, ICEC Coordinator Reproductive Health Supplies Coalition Membership Meeting.

Strengthening the Protection of Intellectual and Industrial Property Rights Deputy Manager Jan Hylleberg The Danish Association of the Pharmaceutical Industry.

preventing counterfeit …

First Evaluation of Good Governance for Medicines Programme Brief Summary of Findings.

WHO Good Governance for Medicines programme Technical Briefing Seminar 19 November 2009, Geneva Dr Guitelle Baghdadi-Sabeti Department of Essential Medicines.

Food Safety Export Assurance System Requirements for Dairy Products Confidential to Fonterra Co-operative Group September 2014 Malcolm Bailey – Fonterra.

SCHEDULING OF MEDICINES SAPRAA 13 June Scheduling of Medicines Ephedrine Pseudoephedrine D-nor-pseudoephedrine.

1 Promoting Safe Medicine With Track and Trace Systems SRC Technologies, Inc.

Industrial Railways: An Emerging Sector Presentation to the Industrial Railway Safety Conference Michael Bourque President and C.E.O. of the Railway Association.

Geneva, Switzerland, November 2014 United Arab Emirates Experience Ahmad Alshamsi Manager Type Approval, UAE TRA Combating.

CPMA Repacking and Wholesale Food Safety Program August 14 th, 2006 Calgary, AB.

Drug Discovery Exchange Fellowship Workshop 9 th -10 th December Mike Hardman IMI EMTRAIN Coordinator.

United States-Canada Regulatory Cooperation Council United States-Canada Regulatory Cooperation Council January 30, 2012 Washington D.C

Public Health, Innovation and Intellectual Property Improving access to medicines through local production: Some New Development I P C Meeting, Copenhagen.

 Pharmacovigilance – Patient’s standpoint Steve Arlington May 2007.

> In April of 2007, Main Pharmaceutical Inspector created special position for combating counterfeit and illegal medicines > In May,

Aflatoxins in Zimbabwe Legislative Frameworks Against Level of Awareness A Perspective from a Laboratory Paper presented by Nozipo Nziramasanga At Huang.

Pharmaceutical Manufacturers Association PMA Status of National Production Capacity of Generic Medicines – Private Sector Perspective Emmanuel Mujuru,

Building Bridges… National & International Food Safety Regulations

Corporate Responsibility and Third Party Relationships GSK and Contract Manufacturers James Hagan Vice President Corporate Environment, Health & Safety.

Johnson & Johnson Overview Incorporated in 1887: Listed on NYSE in 1944 symbol JNJ 250 operating companies, 117K employees in 57 countries Three business.

Saving Lives, Saving Money Lilia Bounab – Healthcare Sales Manager EMEA Ar ł amów hotel, 14-16th June 2015.

CBP National Trade Strategy Winter Presenter’s Name June 17, 2003 CBP’s Trade Vision  CBP’s trade vision is to develop a swift, safe, and secure.

Medicines Transparency Alliance27/10/ MeTA Ghana Augustina Koduah (Mrs) Country Coordinator.

MeTA Medicines Transparency Alliance: Under New Management Dr Tim Reed Director, Health Action International (Global) International MeTA Secretariat.

Cloud Computing, Policy Management and Standardization Europe Identity Conference 2011 John Sabo, Director Global Government Relations, CA Technologies.

WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.

Quality & Safety of Generic Drugs in the World Market World Bank Conference “Good Intentions – Bad Drugs” March 10, 2005 Washington, D.C. Christine Simmon.

INTRODUCTION AND OBJECTIVES LEGAL ASPECTS AND SOCIO-ECONOMIC IMPLICATIONS REGARDING DRUG COUNTERFEITING CIOBANU CONSTANTIN, CORCIOVĂ ANDREIA Faculty of.

Dr Mary Couper Quality Assurance and Safety of Medicines WHO

“Supporting the Industry through Communication” The pharmaceutical industry is committed to the research, development, quality manufacturing and logistics.

Government functions in the Economy  Stabilize the economy  Provide Public Goods  Regulation of Business, Labor, Agriculture  Redistribute Income…Entitlements.

Single Competency Framework for Prescribers National Prescribing Centre (2012)

Issues related to poor IP protection in EMs: Pharmaceutical Example Rob May Commercial Director, Janssen, EMEA Emerging Markets.

IPEC Overview The Impact of Globalisation and IPEC’s Role Janeen Skutnik Past Chair – IPEC Americas.

PARTNERSHIP FOR TB CARE AND CONTROL IN INDIA Inception : The Partnership has its roots in a Round 8 proposal for the Global Fund. In August 2008, USAID.

Pharmaceutical Working Group Working Group on Pharmaceuticals Key Points for Advocacy and Action.

An agency of the European Union Sharing Our Vision? A view from the European Medicines Agency PGEU Symposium, 17 June 2013, Rome Presented by: Guido Rasi.

The Transposition of the Falsified Medicines Directive – the UK story

1 IMPACT: the International Medical Products Anti-Counterfeiting Taskforce Peter Munyi LLM Christa Cepuch BSc Phm UNSR EAC Consultation, Nairobi 10 – 12.

Conducting business the right way Nobody should get hurt or made unwell by what we do GROUP HEALTH, SAFETY & WELLBEING POLICY Version 1 [August 2016]

PRESENTATION ON THE STATUS AND THE BUDGET OF THE RAILWAY SAFETY REGULATOR TO THE PORTFOLIO COMMITTEE ON TRANSPORT PARLIAMENT OF THE REBUPLIC OF SOUTH.

ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS

EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.

EXPECTED EFFECTS OF SERIALIZATION SYSTEM IMPLEMENTING FROM THE STANDPOINT OF REGULATORY AUTHORITY 3-4 DECEMBER SHAKARYAN MKRTICH.

The American Public Health Association’s 2007 Annual Meeting & Exposition November 7, 2007.

Safe Online Pharmacies

Introduction to TransCelerate

Aflatoxins in Zimbabwe Legislative Frameworks Against Level of Awareness A Perspective from a Laboratory Paper presented by Nozipo Nziramasanga At Huang.

Fight Against Falsified medicines

Pharmaceutical Quality Group David Abraham

Counterfeiting and Intellectual property theft in Medicines World Bank Symposium March 10, 2005 Washington DC Frederick Razzaghi Director of Technical.

An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

Presentation transcript:

PSM India Bejon Misra, Founder Director

Mission Committed to the safety of prescription drugs and protecting consumers against spurious, counterfeit, falsified, substandard or otherwise unsafe medicines Vision Just One Unsafe Medicine Threatens Patient Safety… we all must work together to educate and to help protect patients in India and around the globe PSM India

PSM International Principles for Drug Safety Secure and protect the supply chain Regulate online drug sellers Unify the fight against counterfeit drugs 1 2 3

 Successful partnerships including all levels of Indian government across various Ministries and States  Indian pharmaceutical industry buy-in  Public education campaign with regular Newsletter, dynamic website and toll-free 24/7 Helpline PSM India’s Efforts

 Indian consumers finally have the ability to educate themselves on the dangers of fake medicines  Indian government is more aware of risks and more willing to crack down on counterfeit producers  Recognised as trusted partner in the pharmaceutical sector on patient safety and quality medicines PSM India: Results

 Collaborating with PSM China, PSM Board members and senior Ministry Officials to exchange best practices  Government of India invited PSM as implementing partner in research studies  Example: Audit of drugs bound for export for compliance with 2D barcoding regulation PSM India in 2014

 PSM/Board members advising new Modi government on health- related issues including safe medicines  PSM outreach extended to pharmacovigilance  Expanded programs with State drug regulatory officials PSM India in 2014

PSM India: The Future  How to procure safe medicines (generic & branded) from secure sources  Educate consumers to report adverse drug reactions  Strengthen the national pharmacovigilance system  Create champions as whistleblowers to report unethical practices and expose the culprits

Consumer Empowerment is the Key Demo manufacturer authenticates genuine pack of XXXX. Batch No. XXXX Thank you for verifying your